Price T Rowe Associates Inc. MD Invests $217,000 in Surmodics, Inc. (NASDAQ:SRDX)
Price T Rowe Associates Inc. MD bought a new position in shares of Surmodics, Inc. (NASDAQ:SRDX – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 5,469 shares of the company’s stock, valued at approximately $217,000. Other hedge funds have also […]
